METTL3 and hepatocellular carcinoma: There is also an opinion suggesting that blocking p53 mRNA m6A modification by S‐adenosyl homocysteine or siRNA‐mediated METTL3 inhibition increases susceptibility of hepatocellular carcinoma to chemotherapy.56